Latest news articles

Added 2 days ago Drug news

Positive phase III ACHIEVE I trial results for ubrogepant published in NEJM.- Allergan

Allergan plc announced that positive results from ACHIEVE I (UBR-MD-01), a robust Phase III clinical trial evaluating the efficacy, safety...

Added 18 days ago Drug news

Positive phase III ACHIEVE II trial results for ubrogepant published in The Journal of the American Medical Association.- Allergan

Allergan plc announced that positive results from ACHIEVE II (UBR-MD-02), a pivotal Phase III clinical trial evaluating the efficacy, safety...

Search all news articles for Headache
 

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Migraine Knowledge Centre

Migraine Knowledge Centre

The Migraine Knowledge Centre features latest research on the prevalence and impact of migraine, the proposed neurological basis of the condition (and how this is being translated into new and exciting drug therapies), as well as current patient care strategies collated from headache organisations worldwide.

EPNS 2019 Congress Highlights

EPNS 2019 Congress Highlights

The epgonline.org team is creating daily reports from the 13th European Paediatric Neurology Society (EPNS) Congress, held in Athens, Greece from 17th to 21st September 2019, to bring you coverage of cutting-edge science and advances in clinical care across all fields of paediatric neurology. 

Load more

Guidelines

Suspected neurological conditions: recognition and referral

This guideline covers the initial assessment of symptoms and signs that might indicate a neurological condition. It helps non-specialist healthcare professionals to identify people who should be offered referral for specialist investigation.

Added 3 months ago

Pharmacological management of migraine

This guideline provides recommendations on the pharmacological management of adults with acute migraine, and prophylaxis for patients with episodic or chronic migraine or medication overuse headache.

Added 3 months ago

Treatment of medication overuse headache – guideline of the EFNS headache panel

Medication overuse headache is a common condition with a population-based prevalence of more than 1–2%. Treatment is based on education, withdrawal treatment (detoxification), and prophylactic treatment.

Added 8 years ago

Search all guidelines for Headache
 

Journal articles

Erenumab for episodic migraine prophylaxis.

Introduction: This paper reviews placebo-controlled randomized double-blind studies with erenumab for the prevention of migraine. Erenumab is a fully human monoclonal antibody (mAb), which specifically blocks the calcitonin...

Added 13 days ago

Symptoms related to the visual system in migraine.

Migraine is a common headache disorder characterized by often-severe headaches that may be preceded or accompanied by a variety of visual symptoms. Although a typical migraine aura is not difficult to diagnose, patients with...

Added 13 days ago

Transient Neurologic Dysfunction in Migraine.

Transient disturbances in neurologic function are disturbing features of migraine attacks. Aura types include binocular visual, hemi-sensory, language and unilateral motor symptoms.

Added 13 days ago

Search all journal articles for Headache
 

Clinical trials

Evaluate Efficacy & Safety of Eptinezumab Administered Intravenously in Subjects Experiencing Acute Attack of Migraine (RELIEF)

The purpose of this study is to evaluate the efficacy and safety of eptinezumab administered intravenously in subjects experiencing an acute attack of migraine.

Added 13 days ago

Initiating Early Control of Migraine Pain and Associated Symptoms (INTERCEPT)

AXS-07 is an oral, investigational medicine consisting of MoSEIC meloxicam and rizatriptan, which is being developed for the acute treatment of migraine with or without aura in adults.

Added 13 days ago

A Study of Lasmiditan (LY573144) Over Four Migraine Attacks

The reason for this study is to see how effective and safe the study drug known as lasmiditan is in the acute treatment of 4 migraine attacks with or without aura.

Added 13 days ago

Search all clinical trials for Headache
 

CME

Tricyclic antidepressants and headaches: systematic review and meta-analysis

Accrediting body
Union of European Medical Specialists (via European Accreditation Council for CME)
Credits available
1
Registration required
1
Subscription fee
90

Persistent headache - red flag symptoms

Accrediting body
MIMS Learning - Monthly Index of Medical Specialities
Credits available
0
Registration required
1
Subscription fee
0

Headache and migraine: clinical review

Accrediting body
MIMS Learning - Monthly Index of Medical Specialities
Credits available
2
Registration required
1
Subscription fee
0
Search all CME for Headache